Trupanion Inc (TRUP) Expected to Announce Earnings of -$0.02 Per Share

Share on StockTwits

Equities research analysts expect that Trupanion Inc (NASDAQ:TRUP) will report ($0.02) earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Trupanion’s earnings, with estimates ranging from ($0.03) to $0.00. Trupanion reported earnings per share of $0.01 during the same quarter last year, which suggests a negative year over year growth rate of 300%. The firm is scheduled to issue its next quarterly earnings results on Thursday, November 1st.

According to Zacks, analysts expect that Trupanion will report full year earnings of ($0.09) per share for the current year, with EPS estimates ranging from ($0.11) to ($0.05). For the next year, analysts anticipate that the firm will report earnings of $0.11 per share, with EPS estimates ranging from ($0.05) to $0.26. Zacks Investment Research’s EPS averages are an average based on a survey of research analysts that that provide coverage for Trupanion.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings results on Thursday, August 2nd. The financial services provider reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.05) by $0.04. Trupanion had a negative net margin of 0.84% and a negative return on equity of 4.43%. The company had revenue of $73.39 million for the quarter, compared to analyst estimates of $72.70 million. During the same quarter last year, the business earned ($0.02) earnings per share. Trupanion’s revenue was up 25.9% compared to the same quarter last year.

Several research analysts have recently issued reports on TRUP shares. BidaskClub upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a report on Tuesday, May 22nd. ValuEngine upgraded shares of Trupanion from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 2nd. Stifel Nicolaus increased their price objective on shares of Trupanion from $34.00 to $40.00 and gave the company a “buy” rating in a report on Tuesday, July 10th. Craig Hallum started coverage on shares of Trupanion in a report on Thursday, July 19th. They issued a “buy” rating and a $55.00 price objective for the company. Finally, Canaccord Genuity increased their price objective on shares of Trupanion from $40.00 to $46.00 and gave the company a “buy” rating in a report on Friday, August 3rd. One research analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and an average target price of $45.13.

Shares of NASDAQ:TRUP traded up $1.08 during trading hours on Friday, hitting $37.37. The stock had a trading volume of 264,997 shares, compared to its average volume of 336,615. Trupanion has a 1-year low of $20.52 and a 1-year high of $46.70. The firm has a market capitalization of $1.25 billion, a P/E ratio of -533.86 and a beta of 0.58. The company has a current ratio of 3.04, a quick ratio of 3.04 and a debt-to-equity ratio of 0.16.

In other news, insider Darryl Rawlings sold 4,000 shares of the stock in a transaction that occurred on Friday, June 15th. The shares were sold at an average price of $39.17, for a total value of $156,680.00. Following the completion of the transaction, the insider now directly owns 1,351,976 shares in the company, valued at $52,956,899.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Murray B. Low sold 3,000 shares of the stock in a transaction that occurred on Friday, August 10th. The shares were sold at an average price of $38.12, for a total transaction of $114,360.00. Following the completion of the transaction, the director now owns 189,782 shares of the company’s stock, valued at $7,234,489.84. The disclosure for this sale can be found here. Insiders sold 23,300 shares of company stock valued at $920,002 over the last quarter. Insiders own 20.70% of the company’s stock.

A number of large investors have recently modified their holdings of the stock. Boston Advisors LLC boosted its holdings in Trupanion by 16.2% during the second quarter. Boston Advisors LLC now owns 8,070 shares of the financial services provider’s stock worth $312,000 after buying an additional 1,127 shares in the last quarter. State Board of Administration of Florida Retirement System boosted its holdings in Trupanion by 15.7% during the second quarter. State Board of Administration of Florida Retirement System now owns 13,322 shares of the financial services provider’s stock worth $514,000 after buying an additional 1,811 shares in the last quarter. Swiss National Bank boosted its holdings in Trupanion by 6.3% during the first quarter. Swiss National Bank now owns 33,910 shares of the financial services provider’s stock worth $1,014,000 after buying an additional 2,000 shares in the last quarter. Rhumbline Advisers boosted its holdings in Trupanion by 9.9% during the second quarter. Rhumbline Advisers now owns 22,407 shares of the financial services provider’s stock worth $865,000 after buying an additional 2,015 shares in the last quarter. Finally, US Bancorp DE boosted its holdings in Trupanion by 111.8% during the second quarter. US Bancorp DE now owns 4,512 shares of the financial services provider’s stock worth $175,000 after buying an additional 2,382 shares in the last quarter. Hedge funds and other institutional investors own 94.00% of the company’s stock.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company operates through Subscription Business and Other Business segments. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels.

Recommended Story: Fundamental Analysis and Individual Investors

Get a free copy of the Zacks research report on Trupanion (TRUP)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply